CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Analysts give CAMP4 a consensus rating of “Moderate Buy” from six firms (1 sell, 1 hold, 4 buy) with an average 12‑month price target of $9.00.
• Shares traded at about $4.58 mid‑day (market cap ~$237.8M); the company reported Q4 EPS of ($0.87), missed estimates, posted just $0.35M revenue and very negative margins/ROE, though several large investors (including Goldman Sachs and Bank of America) recently initiated small positions.

CAMP4 Therapeutics Corporation (NASDAQ:CAMP - Get Free Report) has received a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $9.00.

CAMP has been the topic of a number of research reports. Weiss Ratings restated a "sell (e+)" rating on shares of CAMP4 Therapeutics in a report on Monday, December 29th. Leerink Partners raised their price objective on CAMP4 Therapeutics from $8.00 to $9.00 and gave the stock an "outperform" rating in a report on Thursday, April 2nd. Finally, Cantor Fitzgerald restated an "overweight" rating on shares of CAMP4 Therapeutics in a report on Friday, March 6th.

CAMP4 Therapeutics Trading Down 1.5%

Shares of CAMP traded down $0.07 during mid-day trading on Wednesday, reaching $4.58. The company had a trading volume of 39,079 shares, compared to its average volume of 187,653. The stock has a market cap of $237.79 million, a price-to-earnings ratio of -1.72 and a beta of 0.41. The firm has a fifty day simple moving average of $2.59 and a 200-day simple moving average of $3.59. CAMP4 Therapeutics has a fifty-two week low of $1.30 and a fifty-two week high of $7.75.

CAMP4 Therapeutics (NASDAQ:CAMP - Get Free Report) last announced its quarterly earnings results on Thursday, March 5th. The Wireless communications provider reported ($0.87) earnings per share for the quarter, missing analysts' consensus estimates of ($0.31) by ($0.56). The company had revenue of $0.35 million during the quarter. CAMP4 Therapeutics had a negative net margin of 2,298.54% and a negative return on equity of 162.49%. As a group, equities analysts predict that CAMP4 Therapeutics will post -4.99 EPS for the current fiscal year.

Hedge Funds Weigh In On CAMP4 Therapeutics

Large investors have recently modified their holdings of the company. Bridgeway Capital Management LLC purchased a new position in shares of CAMP4 Therapeutics in the 2nd quarter worth about $36,000. China Universal Asset Management Co. Ltd. purchased a new position in shares of CAMP4 Therapeutics in the 4th quarter worth about $61,000. Jefferies Financial Group Inc. purchased a new stake in shares of CAMP4 Therapeutics during the 4th quarter valued at about $70,000. Bank of America Corp DE purchased a new stake in shares of CAMP4 Therapeutics during the 4th quarter valued at about $86,000. Finally, Goldman Sachs Group Inc. purchased a new stake in shares of CAMP4 Therapeutics during the 4th quarter valued at about $115,000.

CAMP4 Therapeutics Company Profile

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.